Related Experiment Video
Updated: Jun 13, 2026

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
Published on: February 10, 2023
Treatment of pericardial disease
1Division of Cardiovascular Medicine, University Hospitals Case Medical Center, Cleveland, OH, USA. bdh6@case.edu
Abstract:
The pericardium is composed of visceral and parietal components. In view of the pericardium's simple structure, pathologic processes involving it are understandably few. However, despite a limited number of clinical syndromes, the pericardium is affected by virtually every category of disease, including infectious, neoplastic, immune-inflammatory, metabolic, iatrogenic, and traumatic. Thus, the recognition of pericardial heart disease remains challenging. Treatment of pericardial disease is also problematic in that there is a paucity of randomized, placebo-controlled trials from which appropriate therapy may be selected and important clinical decisions assisted. This article reviews pericarditis and its sequelae, pericardial effusions, cardiac tamponade and constrictive pericarditis.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
Pericarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management

